Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-02

FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for NORPRAMIN (desipramine hydrochloride) filed by Validus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORPRAMIN (Desipramine hydrochloride)

Snippet

SUPPL AP for NORPRAMIN (DESIPRAMINE HYDROCHLORIDE)